Caribou Biosciences, Inc.(CRBU)
Biotechnology
Cell Therapy (CAR-T, etc.)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | Kelly Timothy P Chief Technology Officer | Sale | -6,228 | -7.85%73,125 | $1.93 | $12,020 | View SEC filing | |
| 2026-02-24 | Albertson Tina M. Chief Medical Officer | Sale | -1,066 | -1.53%68,523 | $1.96 | $2,089 | View SEC filing | |
| 2026-02-24 | Khan Ruhi Ahmad Chief Business Officer | Sale | -6,938 | -6.20%104,998 | $1.96 | $13,598 | View SEC filing | |
| 2026-02-24 | Kelly Timothy P Chief Technology Officer | Sale | -3,147 | -3.81%79,353 | $1.96 | $6,168 | View SEC filing | |
| 2026-02-24 | MCCLUNG BARBARA G Chief Legal Officer | Sale | -6,938 | -1.42%481,564 | $1.96 | $13,598 | View SEC filing | |
| 2025-03-17 | Haurwitz Rachel E. President and CEO | Purchase | +20,000 | +0.60%3,369,395 | $1.02 | $20,400 | View SEC filing | |
| 2025-02-21 | Khan Ruhi Ahmad Chief Business Officer | Sale | -3,564 | -5.06%66,936 | $1.35 | $4,811 | View SEC filing | |
| 2025-02-21 | Kanner Steven Chief Scientific Officer | Sale | -3,564 | -0.82%431,556 | $1.35 | $4,811 | View SEC filing | |
| 2025-02-21 | MCCLUNG BARBARA G Chief Legal Officer | Sale | -3,564 | -0.80%443,502 | $1.35 | $4,811 | View SEC filing | |
| 2025-01-30 | Ryali Sriram Chief Financial Officer | Purchase | +17,360 | +100.00%17,360 | $1.42 | $24,651 | View SEC filing | |
| 2023-01-20 | Rizvi Syed Ali-aamir Chief Medical Officer | Sale | -5,627 | -8.66%59,373 | $6.31 | $35,506 | View SEC filing | |
| 2022-10-07 | Fischesser Ryan VP of Finance and Controller | Sale | -10,000 | -8.31%110,366 | $10.80 | $107,958 | View SEC filing | |
| 2022-08-26 | Kanner Steven Chief Scientific Officer | Sale | -43,248 | -12.52%302,059 | $11.22 | $485,221 | View SEC filing | |
| 2022-01-12 | Fischesser Ryan VP of Finance and Controller | Purchase | +7,387 | +7.26%109,082 | $4.00 | $29,553 | View SEC filing | |
| 2021-12-21 | Fischesser Ryan VP of Finance and Controller | Purchase | +1,136 | +1.13%101,695 | $2.69 | $3,056 | View SEC filing | |
| 2021-12-08 | MCCLUNG BARBARA G Chief Legal Officer | Purchase | +6,127 | +1.79%348,971 | $2.69 | $16,482 | View SEC filing | |
| 2021-10-21 | MCCLUNG BARBARA G Chief Legal Officer | Purchase | +9,219 | +2.76%342,844 | $2.69 | $24,799 | View SEC filing | |
| 2021-10-13 | Kanner Steven Chief Scientific Officer | Purchase | +114,860 | +114.66%215,031 | $1.92 | $220,757 | View SEC filing | |
| 2021-10-12 | Fischesser Ryan VP of Finance and Controller | Purchase | +1,746 | +1.77%100,559 | $2.69 | $4,697 | View SEC filing |
1-19 of 19